| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advancing High-Quality Value Assessments of Health Care Interventions
|
Doshi, Jalpa A.
|
|
2017
|
20 |
2 |
p. 181-184
4 p.
|
article
|
| 2 |
Advancing Value Assessment in the United States: A Multistakeholder Perspective
|
Sorenson, Corinna
|
|
2017
|
20 |
2 |
p. 299-307
9 p.
|
article
|
| 3 |
Comparing Increments in Utility of Health: An Individual-based Approach
|
Taylor, Matthew
|
|
2017
|
20 |
2 |
p. 224-229
6 p.
|
article
|
| 4 |
Concerns Around Budget Impact Thresholds: Not All Drugs Are the Same
|
Ciarametaro, Michael
|
|
2017
|
20 |
2 |
p. 230-233
4 p.
|
article
|
| 5 |
Copyright/Subscription
|
|
|
2017
|
20 |
2 |
p. iii-
1 p.
|
article
|
| 6 |
Cost-Effectiveness and Dynamic Efficiency: Does the Solution Lie Within?
|
Refoios Camejo, Rodrigo
|
|
2017
|
20 |
2 |
p. 240-243
4 p.
|
article
|
| 7 |
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions
|
Sculpher, Mark
|
|
2017
|
20 |
2 |
p. 234-239
6 p.
|
article
|
| 8 |
Evaluating Frameworks That Provide Value Measures for Health Care Interventions
|
Mandelblatt, Jeanne S.
|
|
2017
|
20 |
2 |
p. 185-192
8 p.
|
article
|
| 9 |
Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments
|
Shafrin, Jason
|
|
2017
|
20 |
2 |
p. 217-223
7 p.
|
article
|
| 10 |
Table of Contents
|
|
|
2017
|
20 |
2 |
p. i-ii
nvt p.
|
article
|
| 11 |
The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care: A Government Perspective Analytic Framework
|
Connolly, Mark P.
|
|
2017
|
20 |
2 |
p. 273-277
5 p.
|
article
|
| 12 |
The HTA Core Model®—10 Years of Developing an International Framework to Share Multidimensional Value Assessment
|
Kristensen, Finn Børlum
|
|
2017
|
20 |
2 |
p. 244-250
7 p.
|
article
|
| 13 |
The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options
|
Mühlbacher, Axel C.
|
|
2017
|
20 |
2 |
p. 266-272
7 p.
|
article
|
| 14 |
The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems
|
Pauly, Mark V.
|
|
2017
|
20 |
2 |
p. 278-282
5 p.
|
article
|
| 15 |
The Value of Addressing Patient Preferences
|
Allen, Jeff D.
|
|
2017
|
20 |
2 |
p. 283-285
3 p.
|
article
|
| 16 |
Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks
|
Cohen, Joshua T.
|
|
2017
|
20 |
2 |
p. 193-199
7 p.
|
article
|
| 17 |
Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis
|
Garrison Jr., Louis P.
|
|
2017
|
20 |
2 |
p. 213-216
4 p.
|
article
|
| 18 |
Toward a Hedonic Value Framework in Health Care
|
Basu, Anirban
|
|
2017
|
20 |
2 |
p. 261-265
5 p.
|
article
|
| 19 |
Using Cost-Effectiveness Analysis to Address Health Equity Concerns
|
Cookson, Richard
|
|
2017
|
20 |
2 |
p. 206-212
7 p.
|
article
|
| 20 |
Using Multicriteria Approaches to Assess the Value of Health Care
|
Phelps, Charles E.
|
|
2017
|
20 |
2 |
p. 251-255
5 p.
|
article
|
| 21 |
Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs
|
Bentley, Tanya G.K.
|
|
2017
|
20 |
2 |
p. 200-205
6 p.
|
article
|
| 22 |
Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values
|
Armstrong, Melissa J.
|
|
2017
|
20 |
2 |
p. 292-295
4 p.
|
article
|
| 23 |
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes
|
Baltussen, Rob
|
|
2017
|
20 |
2 |
p. 256-260
5 p.
|
article
|
| 24 |
Value Assessment in the Regulatory Context
|
Miller, Kathleen L.
|
|
2017
|
20 |
2 |
p. 296-298
3 p.
|
article
|
| 25 |
Value to Whom? The Patient Voice in the Value Discussion
|
Perfetto, Eleanor M.
|
|
2017
|
20 |
2 |
p. 286-291
6 p.
|
article
|
Journal description